The Protein Brewery, a Dutch company specializing in fungi-based food ingredients, has secured €30 million in Series B funding to advance its proprietary mycoprotein, Fermotein®. The funding round involved new investors Invest-NL and the Brabant Development Agency, as well as existing investors Novo Holdings, Unovis Asset Management, and Madeli. The capital will be used to expand production capacity, develop the Fermotein innovation platform, and strengthen commercial presence in the US and Europe.

Fermotein is a high-protein, high-fiber ingredient that can be used in various products like baked goods, snacks, dairy alternatives, and protein shakes. The Protein Brewery aims to redefine how food is made by offering a nutritious, sustainable, and scalable protein option at a lower cost. With plans to launch Fermotein in the US and expand in Singapore, the company is preparing for market launches in the EU and UK pending regulatory approval.